本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fate Therapeutics Inc

2.31
-0.0200-0.86%
盤前2.28-0.0300-1.30%07:57 EDT
成交量:74.24萬
成交額:172.27萬
市值:2.77億
市盈率:-2.19
高:2.39
開:2.36
低:2.30
收:2.33
52周最高:3.23
52周最低:0.9401
股本:1.20億
流通股本:1.05億
量比:0.82
換手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):-1.0528
每股收益(LYR):-1.1500
淨資產收益率:-60.75%
總資產收益率:-26.22%
市淨率:1.81
市盈率(LYR):-2.01

資料載入中...

2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/29

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

SEC問詢函

Form CORRESP - Correspondence
2023/11/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/09/02

重要事件披露

Form 8-K - Current report